PerkinElmer to acquire Oxford Immunotec for USD 22.00 per share in cash Transaction expected to be completed in the first half of 2021 WALTHAM, Mass. & LONDON–(BUSINESS WIRE)–Jan. 7, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) (“Oxford Immunotec” or the “Company”) are pleased to announce they have reached an... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that three world-leading institutions are now accelerating their research into functional structural biology and human disease with new Bruker ultra-high field nuclear magnetic resonance (NMR) spectrometers installed in 2020. Novel GHz-class NMR technology enables advanced research to obtain structural, functional and binding information of intrinsically disordered... Read more
Thermo Fisher Scientific to Present at 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 WALTHAM, Mass., Jan. 6, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference... Read more
Thermo Fisher Scientific Offers Financial Flexibility with New Managed Equipment Solutions New model for instrument and equipment procurement offers customers subscription-based access to technology, and associated consumables, services and support WALTHAM, Mass., Jan. 6, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of Managed Equipment... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 39th annual J.P. Morgan Healthcare Conference, to be held virtually on January 11-14, 2021. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO will present on behalf of the Company on Monday, January 11th, 2021 at 3:40 PM Eastern Standard... Read more
This year 2021 marks the 60th anniversary of the birth of the Remote-controlled Fluoroscopy Table system, which was developed by Shimadzu Corporation for the first time in the world in 1961. 60 years ago, Shimadzu completed the world’s first Remote R/F (Radiography and Fluoroscopy) system and installed it in Osaka Prefectural lifestyle diseases center (currently... Read more
Thermo Fisher Scientific to Hold Earnings Conference Call on Monday, February 1, 2021 WALTHAM, Mass., Jan. 5, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2020 before the market opens on Monday, February 1,... Read more
Breakthrough new paper by Mann-group demonstrates that unbiased, quantitative true single-cell proteomics can address important questions in cell biology and single-cell pathobiology Measured single-cell protein and RNA levels are very different, which implies distinct RNA and protein abundance regulation mechanisms. Protein measurements thus yield complementary quantitative biology information. Results also imply stable cellular core proteomes... Read more
MBT Sepsityper Kit US IVD enables rapid, specific detection of many cases of bacteremia-induced sepsis to assist infectious disease specialists in potentially life-saving decisions Used for MALDI Biotyper® (MBT) identification directly from Positive Blood Cultures (PBC) with short time-to-result (TTR) of less than 30 minutes US FDA clearance received in late December for diagnostic use... Read more
WALTHAM, Mass., Dec. 31, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research.... Read more